$Shuttle Pharmaceuticals (SHPH.US)$ Only 9 employees...

$INVO Fertility (IVF.US)$ Jump in quick

$INVO Fertility (IVF.US)$ The battle has just begun, don't be afraid

$INVO Fertility (IVF.US)$ The stop-loss orders have been triggered, and the price starts to rise

$INVO Fertility (IVF.US)$ TrumpRx.gov platform launch: The Trump administration officially launched the TrumpRx.gov platform in January 2026. By directly connecting manufacturers with consumers, the platform aims to reduce the cost of common fertility drugs such as Gonal-F, Ovidrel, and Cetrotide.
Significant price reduction agreement: The White House has reached an agreement with EMD Serono, the largest fertility drug manufacturer globally and a U.S. branch of Merck KGaA (Germany), to offer discounts of up to 84% on list prices for certain in vitro fertilization (IVF)-related drugs, potentially saving families approximately $2,200 per cycle.
Employer benefit expansion: The new policy allows employers to offer fertility benefits as a 'standalone benefit option' (similar to dental or vision insurance), no longer limited to primary health insurance, thereby encouraging more small and medium-sized businesses to provide IVF coverage for employees.

$INVO Fertility (IVF.US)$Cost basis at $2.5, currently holding the position

$INVO Fertility (IVF.US)$ If you don't act now, it will be too late.

$INVO Fertility (IVF.US)$ Around 6 to 8 yuan.

$INVO Fertility (IVF.US)$Vaginal stock

$Rocket Lab (RKLB.US)$ P/E ratio -250, P/B ratio 40, P/S ratio 80. Truly impressive!